Molybdenum

Evidence Level
Moderate
1 Clinical Trial
4 Documented Benefits
3/5 Evidence Score

Molybdenum is an essential ultratrace mineral required as a cofactor for four known human metalloenzymes: sulfite oxidase (sulfur amino acid metabolism), xanthine oxidase (purine catabolism and uric acid production), aldehyde oxidase (drug/xenobiotic metabolism), and mARC (mitochondrial amidoxime reducing component, involved in nitrogen metabolism). Molybdenum deficiency is extremely rare under normal dietary conditions — the mineral is widely distributed in legumes, grains, and leafy vegetables. It appears in multivitamin formulas primarily for completeness.

Studied Dose 45 mcg/day (RDA for adults); tolerable upper intake level: 2,000 mcg (2 mg)/day; most dietary intakes easily meet RDA; supplemental doses typically 50–150 mcg/day
Active Compound Sodium molybdate or ammonium molybdate — molybdenum bisglycinate chelate for enhanced absorption; extremely small amounts required (mcg/day, not mg/day)
Deficiency information View details

Molybdenum deficiency from diet has essentially never been documented in healthy people — only one case has ever been reported (a man on long-term TPN). Molybdenum is abundant in legumes, whole grains, and leafy vegetables, and human requirements are very low (45 µg/day). The much more serious clinical entity is molybdenum cofactor deficiency — a rare inherited metabolic disorder, NOT a dietary issue.

Common symptoms

  • Documented dietary molybdenum deficiency in humans is essentially nonexistent (1 historical case)
  • In that single TPN case: tachycardia, headache, night blindness, mental disturbances, coma in late stages
  • Inherited molybdenum cofactor deficiency (a separate genetic condition): seizures, severe neurological damage, early infant death — this is NOT dietary

At-risk groups

  • Routine molybdenum supplementation is unnecessary for healthy people
  • Only documented at-risk group: people on long-term parenteral nutrition without molybdenum (rare)
  • Note: 'molybdenum cofactor deficiency' is an inherited enzyme deficiency, not addressable by dietary molybdenum
When to see a doctor: Symptoms attributed to molybdenum deficiency in the general population almost certainly have a different cause. Standalone molybdenum supplementation is rarely necessary. If you encounter products marketing molybdenum for sulfite sensitivity, copper detox, or general wellness, the evidence base is weak. Stay within the UL of 2,000 µg/day to avoid toxicity (gout-like symptoms, joint pain).

Benefits

Sulfite detoxification via sulfite oxidase

Sulfite oxidase — the most critical molybdenum enzyme — converts sulfite (SO₃²⁻) to sulfate (SO₄²⁻), preventing sulfite accumulation. Sulfite is produced during the metabolism of sulfur-containing amino acids (methionine, cysteine) and is found in wine and dried fruits as a preservative. Molybdenum deficiency impairs sulfite detoxification, causing sulfite sensitivity symptoms.

Uric acid production via xanthine oxidase

Xanthine oxidase catalyzes the final two steps of purine catabolism — converting hypoxanthine to xanthine and xanthine to uric acid. This molybdenum-dependent enzyme is the target of allopurinol (gout medication) and is essential for normal purine metabolism. Molybdenum adequacy ensures proper purine catabolism and uric acid clearance.

Xenobiotic and drug metabolism via aldehyde oxidase

Aldehyde oxidase metabolizes numerous endogenous aldehydes, drugs, and environmental chemicals — including retinaldehyde (vitamin A metabolism), benzaldehyde, and several pharmaceutical compounds (zaleplon, ziprasidone, methotrexate). Adequate molybdenum is required for normal drug metabolism, particularly relevant for individuals on aldehyde oxidase-metabolized medications.

Essential completeness in multivitamin formulas

While standalone molybdenum supplementation is rarely indicated, its inclusion in comprehensive multivitamin-mineral formulas ensures complete coverage of all essential micronutrients — particularly relevant for individuals with restricted diets, malabsorption conditions, or low legume/grain intake.

Mechanism of action

1

Molybdenum cofactor (Moco) biosynthesis

Dietary molybdate is incorporated into molybdenum cofactor (Moco) — a tricyclic pyranopterin compound that binds molybdenum and is inserted into all four molybdoenzymes. Moco synthesis is a multi-step pathway conserved across all organisms, and genetic defects in Moco synthesis cause molybdenum cofactor deficiency — a severe inherited metabolic disorder.

2

Oxidative hydroxylation catalysis

Molybdoenzymes catalyze oxidative hydroxylation reactions using water as the oxygen donor — distinct from cytochrome P450 oxidases that use molecular oxygen. This unique reaction mechanism explains the specific substrate profiles of xanthine oxidase and aldehyde oxidase in purine and xenobiotic metabolism.

3

Sulfite oxidase and sulfur amino acid catabolism

Sulfite oxidase in the mitochondrial intermembrane space oxidizes sulfite to sulfate — the terminal step in cysteine and methionine catabolism. Sulfate is then exported for sulfation reactions (glycosaminoglycan synthesis, steroid hormone conjugation) or renal excretion. Without functional sulfite oxidase, sulfite accumulates causing neurological damage.

Clinical trials

1
Molybdenum Deficiency in TPN — Foundational Case Series
PubMed

Clinical case series describing molybdenum deficiency in patients receiving prolonged total parenteral nutrition (TPN) without molybdenum supplementation. (Abumrad et al. 1981, Am J Clin Nutr — the foundational case)

TPN-dependent patients.

Molybdenum-deficient TPN patients developed: hypermethioninemia, low serum uric acid, elevated sulfite excretion, neurological symptoms including encephalopathy. Symptoms reversed with molybdenum supplementation. Established Mo as essential trace mineral. Subsequent work refined RDA. Note: deficiency is essentially confined to TPN context; dietary deficiency is virtually unknown.

Side effects and drug interactions

Common Potential side effects

Extremely well tolerated at dietary and standard supplemental doses (50–150 mcg/day)
High-dose molybdenum (>10 mg/day) can cause gout-like symptoms by increasing xanthine oxidase activity and uric acid production
Very high doses may impair copper absorption — unlikely at normal supplemental doses

Important Drug interactions

Allopurinol — both inhibit xanthine oxidase; theoretical additive effect on uric acid reduction at very high molybdenum doses
Copper — high molybdenum may reduce copper absorption via competitive mechanisms; monitor copper status with very high molybdenum intake
Aldehyde oxidase-metabolized drugs — molybdenum status affects aldehyde oxidase activity; potential influence on drug metabolism at extreme deficiency or excess

Frequently asked questions about Molybdenum

What is Molybdenum?

Molybdenum is an essential ultratrace mineral required as a cofactor for four known human metalloenzymes: sulfite oxidase (sulfur amino acid metabolism), xanthine oxidase (purine catabolism and uric acid production), aldehyde oxidase (drug/xenobiotic metabolism), and mARC (mitochondrial amidoxime reducing component, involved in nitrogen metabolism)…

What does Molybdenum do?

Dietary molybdate is incorporated into molybdenum cofactor (Moco) — a tricyclic pyranopterin compound that binds molybdenum and is inserted into all four molybdoenzymes. In clinical research, Molybdenum has been studied for sulfite detoxification via sulfite oxidase, uric acid production via xanthine oxidase, xenobiotic and drug metabolism via aldehyde oxidase.

Who should take Molybdenum?

Molybdenum may be most beneficial for: Routine molybdenum supplementation is unnecessary for healthy people; Only documented at-risk group: people on long-term parenteral nutrition without molybdenum (rare); Note: 'molybdenum cofactor deficiency' is an inherited enzyme deficiency, not addressable by dietary molybdenum. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Molybdenum take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Molybdenum?

Molybdenum can typically be taken with breakfast or dinner — taking with food reduces GI sensitivity for most supplements. Specific timing matters less than daily consistency for cumulative effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Molybdenum worth taking?

Molybdenum has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Molybdenum is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Molybdenum?

The clinically studied dose for Molybdenum is 45 mcg/day (RDA for adults); tolerable upper intake level: 2,000 mcg (2 mg)/day; most dietary intakes easily meet RDA; supplemental doses typically 50–150 mcg/day. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Molybdenum used for?

Molybdenum is studied for sulfite detoxification via sulfite oxidase, uric acid production via xanthine oxidase, xenobiotic and drug metabolism via aldehyde oxidase. Sulfite oxidase — the most critical molybdenum enzyme — converts sulfite (SO₃²⁻) to sulfate (SO₄²⁻), preventing sulfite accumulation.